TickerFacts.

Traws Pharma, Inc. (TRAW): Capital Expenditures

Annual figures by period end, from SEC filings.

$2.58M
Year ended 2025-12-31
$3.65M2024-12-31: $3.65M2025-12-31: $2.58M$2.58M
2024-12-31 Capital Expenditures (USD) 2025-12-31
Period endedCapital ExpendituresChange YoYSource filing
2025-12-31$2.58M-29.1%2026-04-15, From 2025-01-01
2024-12-31$3.65Mn/a2026-04-15, From 2024-01-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
Traws Pharma, Inc. (TRAW)2025-12-31$2.58M-29.1%
Longeveron Inc. (LGVN)2025-12-31$245.0K-62.6%
Lantern Pharma Inc. (LTRN)2025-12-31$1.7K-86.4%
Decoy Therapeutics Inc. (DCOY)2025-12-31$577.0Kn/a
MetaVia Inc. (MTVA)2025-12-31$2.0K-75.0%
NewcelX Ltd. (NCEL)2025-12-31$8.0K+33.3%
Revelation Biosciences, Inc. (REVB)2024-12-31$19.2Kn/a
Cocrystal Pharma, Inc. (COCP)2025-12-31$12.0K+50.0%
FibroBiologics, Inc. (FBLG)2025-12-31$262.0K+42.4%

Compare TRAW, LGVN, LTRN, DCOY side by side · Screen every company in Pharmaceutical Preparations ↗